ESTRO 2025 - Abstract Book

S2275

Interdisciplinary – Health economics & health services research

ESTRO 2025

Keywords: Radiotherapy: Access: Global

References: 1. Barton M, Jacob S, Shafiq J. Review of optimal radiotherapy utilisation rates. Prepared fo Department of Health and Aging, Australian government 2013; Australia: Ingham Institute. Retrieved from tinyurl.com/pwkua34 2. Hanna TP, Shafiq J, Delaney GP, Vinod SK, Thompson SR, Barton MB. The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. Radiother Oncol 2018; 126: 191–197. https://doi.org/10.1016/j.radonc.2017.11.004 The data for this publication has been made possible through the sharing of a dataset developed and supported by the ICCP ( https://www.iccp-portal.org/)

1154

Digital Poster Time to Initial Consultation and Determinants of Delays in Radiation Oncology for Patients with Breast and Gynecologic Cancer Ana L. Rivero Pérez 1 , Javier T. Anchuelo Latorre 2 , Pedro J. Prada Gómez 1 , Frandeína Pinto Guevara 1 , Mara García Lamela 1 , Francisco J. Olloqui Urroz 1 , Alejandra Perez Gonzalo 1 , Paola A. Navarrete Solano 1 , Maria P. Galdós Barroso 1 , Cristina Rodriguez Acosta Caballero 1 , Rosa Fabregat Borras 3 , Marina Gutierrez Ruiz 3 , Patricia Sarrion Rubio de la Torre 1 , Amaia Ilundain Idoate 1 , Marian A. Cobo Belmonte 1 , Ivan Diaz de Cerio Martínez 1 , Uriel A. Corro Verde 1 , Ana S. García Blanco 1 , Juan Cardenal Carro 1 , Javier Albendea Roch 1 , Enrique Capón Saez 1 , Paula Delgado Tapia 3 , Noelia Suarez Alvarez 3 , Jose A. Vazquez Rodríguez 3 , Juan I. Raba Diez 3 1 Radiation Oncology Department, Marqués de Valdecilla University Hospital, Santander, Spain. 2 Radiation Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain. 3 Medical Physics Department, Marqués de Valdecilla University Hospital, Santander, Spain Purpose/Objective: To assess the response time of our Radiation Oncology Department for patients with breast and gynecologic cancers and to identify factors associated with delays in care. Material/Methods: We retrospectively analyzed the interval from referral registration to initial consultation for patients in the breast and gynecology departments between June 2023 and February 2024 using electronic medical records. Time to consultation was measured in days. Patients with urgent radiotherapy needs, such as spinal cord compression, who received same-day treatment were excluded from the analysis. Results: A total of 295 patients were included, of whom 230 had breast cancer and 65 had gynecologic cancer. The average time from referral to first consultation was 6.4 days. Among these, 186 patients (62.4%) were seen within 7 days, 54 patients (18%) between 8 and 10 days, and 58 patients (19.5%) after 10 days. Analysis of patients experiencing delays beyond 7 days revealed that 44.6% had received prior chemotherapy, 34% presented during the summer holiday period, and 21.4% experienced delays due to other factors.